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Abstract
Genetically modified organisms (GMOs), are organisms made 
for agricultural or industrial or medical purpose into which one or 
several genes arraying for desirable traits through the process of 
genetic engineering. GMO trade tends to expand every year 
regardless of the increasing number of people who question the safety 
of GM foods and their influence on human health and the ecosystem.
This study aims to examine the connection between the 
international trade of GMOs and the WTO Agreement on Trade-
Related Aspects of Intellectual Property Rights (TRIPS), and to 
clarify issues of GMO trade in the WTO legal framework. In the 
introduction, this paper has offered an outline of GMOs classified 
by three generations, and the expansion of first-generation GMO 
trade. It also explained the concerns about GMOs in relation to 
human health and the environment. In the first section, this paper 
dealt with the history of the establishment of the TRIPS 
Agreement, and clarified issues concerning the international trade 
of GMOs in the context of the Agreement. In the second section, 
this paper explained the characteristics of the legal system as 
viewed from the perspective of the autopoietic system, and 
discussed the possibility of resonance between the legal system and 
the environment concerning GMOs, such as the risk assessment of 
GMOs or the principle of protection for traditional knowledge. 
Finally, This paper tries to show the perspective in the future of the 
regulation for GMO trade.
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INTRODUCTION
The science and technology has the possibility to solve several prob-
lems which human beings have being suffering, the other hand, it also has 
the possibility to threaten peoples’ lives, even over the border such as the 
accident of the nuclear power plant at Fukushima which followed the To-
hoku earthquake. Especially, biotechnology, in its character, is fraught 
with unlimited danger for the society to be connected with agriculture, in-
dustry, medicine and pharmaceuticals. Above all, the genetically modified 
organisms (GMOs) have been already brought to market and been close to 
our lives therefore how to regulate the GMOs and its trade is significant 
today. This study aims to examine the connection between the internation-
al trade of GMOs and the WTO Agreement on Trade-Related Aspects of 
Intellectual Property Rights (TRIPS), and to clarify issues of GMO trade 
in the WTO legal framework.
Genetically modified organisms (GMOs) can be defined as organisms, 
‘with the exception of human beings, in which the genetic material has 
been altered in a way that does not occur naturally by mating and/or natu-
ral combination’.1) GMOs are organisms made for agricultural or industri-
al or medical purpose into which one or several genes arraying for desira-
ble traits through the process of genetic engineering.The technique of 
genetic engineering was developed in the 1980s, and commercial applica-
tion began in the 1990s. In the agricultural field, it has undergone re-
markable development, and presently, about 10 percent of farmlands in 
the world are used for growing genetically modified (GM) crops or transge-
netic plants.2) 
 1)  2001/18/EC of 12 March 2001 on the deliberate release into the environment of genetically 
modified organisms and repealing Council Directive 90/220/EEC, Official Journal of the 
European Communities, Legislation106/ 17 (2001), Article 2(2).
 2)  Clive James, “Global status of commercialized biotech/GM crops: 2008”, ISAAA Briefs 39 
(2008).
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GM crops can be classified into three categories.3)
①First-generation
First-generation GM crops involve improvements in the traits of soil 
management and crop production, such as better resistance to diseas-
es, viruses, bacteria, harmful insects and particular herbicides.4) For 
example, there are vegetables and other plants, such as potatoes, egg-
plant, cauliflower, soybeans and cabbage, cotton, canola and rice 
which contain Bacillus thuringiensis (Bt) or are Herbicide Tolerant 
(HT) or virus resistant. Some first-generation GM crops are ready to 
be commercialized.5) First-generation GM crops have attracted the in-
terest of producers because they can increase production efficiency.
②Second-generation
GM technologies which are categorized as second-generation technolo-
gies improve the quality of products. They increase the nutrition con-
tents of food products and provide resistance to dryness and damage 
from salty winds. The products are made to resist environmental 
stress. For example, Golden Rise, which contains beta-carotene, will be 
able to be commercialized in Asian countries by 2012.6) Other research 
projects for second-generation GM such as sorghums, bananas, cassa-
vas and rice which contain multi nutrition are progressing. GM breed-
 3)  Matin Qaim, “The Economics of Genetically Modified Crops”, The Annual Review of Re-
source Economics 1 (2009), pp.667-669.
 4)  Niqel Halford (ed), Plant Biotechnology: Current and Future Uses of Genetically Modified 
Crops (John Wiley & Sons, 2006).
 5)  Bt rice has been tested in China and other countries (Jikun Huang, Ruifa Hu, Scott Ro-
zelle and Carl Pray, “Insect-resistant GM rice in farmers’ fields: assessing productivity and 
health effects in China”, Science 308 (2005), pp.688-690. Bt vegetables can be commercial-
ized soon in India (Vijesh V. Krishna and Matin Qaim, “Estimating the adoption of Bt egg-
plant in India: Who benefits from public-private partnership?”, Food Policy 32 (2007), 
pp.523-543., and Anthony M. Shelton, Marc Fuchs and Frank A. Shotoski, “Transgenic veg-
etables and fruits for control of insects and insect-vectored pathogens” in Jorg Romeis, An-
thony M. Shelton and George G. Kennedy (eds), Integration of Insect-Resistant Genetically 
Modified Crops within IPM Programs (Springer, 2008), pp.249-271.).About HT rice, see 
Guy G. Hareau, Bradford F. Mills, George W. Norton, “The potential benefits of herbicide-
resistant transgenic rice in Uruguay: lessons for small developing countries”, Food Policy 
31 (2006), pp.162-179.
 6)  Alexander J. Stein, H.P.S. Sachdev and Matin Qaim, “Genetic engineering for the poor: 
Golden Rice and public health in India”, World Dev. 36 (2008), pp.144-158.
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ing is also called biofortification.7) The projects focusing on second-
generation GM crops are related to the interests of consumers and to 
new application fields.
③Third-generation 
Third-generation GM crops are designed for pharmaceutical or indus-
trial purposes, and they include monoclonal antibodies and vaccines, 
and the technologies for biodegradable industrial materials.8) The con-
cepts of third-generation GM have been proven, and research projects 
are progressing which aim to bring the third-generation GM to mar-
ket. However, there are still problems in that third-generation GM 
crops must not enter the regular food chain.9)
Some first-generation GMOs have already been commercialized. GM 
crops are attractive to farmers who wish to increase productivity and re-
duce the cost of production and management time.10) Furthermore, they 
have substantial environmental and health benefits. They provide the pos-
sibility of aiding in the reduction of soil erosion, fuel use and greenhouse 
gas emissions because these crops require much less toxic herbicide, insec-
ticide and tillage operations.11) Because farmers use significantly less 
chemical pesticide, the crops that are produced are healthier for farmers 
and consumers.12) GM crops offer more possibilities for developing coun-
tries, as they can resist environmental pressures, provide much nutrition 
and can be grown without rich soils. GM crop technology has the potential 
to increase the amount of food production in developing countries and feed 
growing populations.13) We have high expectations that GMOs could solve 
 7)  Martin Qaim, A. J. Stein, J. V. Meenakshi, “ Economics of biofortification”, Agricultural 
Economics 37, Suppl. 1 (2007), pp.119-133.
 8)  Gian Carlo Moschini, “Pharmaceutical and industrial traits in genetically modified crops: 
coexistence with conventional agriculture”, in The American Journal of Agriculture and 
Economics 88 (2006), pp.1184-1192., and Nigel Halford (ed.), Plant Biotechnology: Current 
and Future Uses of Genetically Modified Crops (John Wiley & Sons, 2006).
 9) Op. cit.(Qaim, 2009), p.669.
 10) Ibid., p.670.
 11)  Matin Qaim and Greg Traxler, “Roundup Ready soybeans in Argentina: farm level and ag-
gregate welfare effects”, Agricultural Economics 32 (2005), pp.73-86.
 12) Op. cit.(Qaim, 2009), p.677.
 13)  Simonetta Zarrilli, “International Trade in GMOs and GM products: National and Multi-
lateral Legal Frame works”, United Nations Conference on Trade and Development, Policy 
issues in International Trade and Commodities Study Series No.29 (2005), p.1.
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problems related to agriculture, poverty and the environment.     
On the other hand, people have shown concern about potential envi-
ronmental risks that destroy ecosystems or the natural environment, and 
about food security.14) A major concern for the environment relates to the 
potential consequences of genes which are made through bioengineering 
and are transmitted by GMOs to humans. Another environmental concern 
is that increasing dependence on a few GM crops could threaten the 
world’s biological diversity. These crops might also increase the vulnerabil-
ity of non-GM crops to disease or insects. Such issues may also lead to eth-
ical and religious concerns about GMOs. Patents are an economic problem 
related to GMOs. GMOs are intellectual properties which are researched 
mainly by agricultural or pharmaceutical companies. A large number of 
patents may lead to GM crops being too expensive for poor farmers to buy, 
especially in developing countries.15)
Although the environmental, health, economic and ethical risks of 
GMOs cannot be denied, GMOs have recently become widespread. For ex-
ample, Bt cotton estimated economic surplus of approximately 164 million 
dollars in the United States in 1999,16) approximately 140 million dollars 
in China in 1999,17) and approximately 315 million dollarsin India in 
2005.18) Bt maize estimated economic surplus of approximately 334 million 
dollars in the United States in 2001,19) and 2 million dollars in Spain cov-
ered only area of approximately 25,000 ha in 2003.20)
Because of people’s concern about the expansion of GM crops, which 
have multilateral potential risks, developed and developing countries have 
 14)  Op. cit.(Qaim, 2009), p674. And Sean A. Weaver and Michael C. Morris, “Risks associated 
with genetic modification: an annotated bibliography of peer-reviewed natural science pub-
lications”, Journal of Agricultural and Environmental Ethics 18 (2005), pp.157-189.
 15) Op. cit.(Zarrilli), p.2.
 16)  Gregory K. Price, William Lin, José B. Falck-Zepeda and Jorge Fernandez-Cornejo, “The 
size and distribution of market benefits from adopting agricultural biotechnology crops”, in 
The United States Department of Agriculture, Economic Research Service, Technical bulle-
tin No.1906 (2003).
 17)  Carl Pray, Danmeng Ma, Jikun Huang and Fangbin Qiao, “Impact of Bt cotton in China”, 
World Development 29 (2001), pp.813-825.
 18)  Matin Qaim, “Bt cotton in India: field trial results and economic projections”, World Devel-
opment 31 (2003), pp.2115-2127.
 19)  F. Wu, “Bt or not Bt? Tools for regulatory decisions concerning genetically modified corn”, 
PhD. Thesis (Public Policy, Carnegie Mellon University, 2002).
 20)  M. Demont and E. Tollens, “First impact of biotechnology in the EU: Bt maize adoption in 
Spain”, Annals of Applied Biology 145 (2004), pp.197-207.
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established domestic regulations on GMOs.21) The international trade of 
GMOs is regulated according to World Trade Organization (WTO) rules. In 
particular, the Agreement on the Application of Sanitary and Phytosani-
tary Measures (SPS Agreement) is related to the international trade of 
GMOs. Presently, the WTO Agreement on Trade-Related Aspects of Intel-
lectual Property Rights (TRIPS) also has a considerable relation to the in-
ternational trade of GMOs.22)
This study aims to examine the connection between the international 
trade of GMOs and the WTO Agreement on Trade-Related Aspects of In-
tellectual Property Rights (TRIPS), and to clarify issues of GMO trade 
within the WTO legal framework. The introduction of this paper explains 
GMOs and the trade of these products. The first section deals with the 
TRIPS Agreement and clarifies issues concerning the international trade 
of GMOs in the context of this agreement. The second section explains the 
characteristics of the legal system as viewed from the autopoietic system 
and discusses the possibility of the resonance between the legal system 
and the risk assessment of GMOs. Finally, the study attempts to offer a 
perspective for future GMO trade regulation.
1. INTERNATIONAL TRADE OF GMOS IN THE CONTEXT OF TRIPS
1-1. The TRIPS Agreement 
The agreement on Trade-Related Aspects of Intellectual Property 
Rights (TRIPS Agreement), together with the Berne and Paris Conven-
tions which established the World Intellectual Property Organization 
(WIPO) at the Stockholm Conference in 1967, are the most important 
agreements for the development of intellectual property.23) The provisions 
of the General Agreement on Tariffs and Trade (GATT) which are related 
to intellectual property rights are Article 9, which is the provision for 
marking the countries of origin, Article 12, which pertains to restrictions 
to safeguard the balance of payments and Article 18, which is the provi-
sion for government assistance to economic development. However, there 
is no provision to protect intellectual property rights directly. TRIPS was 
 21) Op. cit. (Zarrilli), pp.4-23.
 22) Ibid., p.24.
 23)  Daniel Gervais, The TRIPS Agreement: Drafting History and Analysis (Sweet & Maswell, 
2008), p.3.
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enacted as one of the appendixes of the Marrakesh Agreements, which es-
tablished WTO at the GATT Uruguay Round of Multilateral Trade Negoti-
ations in 1994. Previously, the trade of pirated products such as trademark 
infringing products or pirated editions of products was recognized as a se-
rious problem for developed and developing countries because manufac-
turers who have the copyright or the right to the trademark must receive 
economic damages, and, furthermore, there was a decline in brand image 
due to the increasing trades of pirated products.24) Since the GATT Tokyo 
Round, developed countries, mainly the United States, have proposed that 
the protection standards for intellectual property should be improved and 
that a crackdown against pirated products at customs should be enforced. 
At the Tokyo Round, member countries failed to reach an agreement about 
the enforcement of a crackdown against piracy because developing coun-
tries, mainly India and Brazil, expressed a negative view about reaching 
an agreement as the regulation of piracy of each country were too different 
to have an agreement, and, moreover, WIPO already offered intellectual 
property standards. This proposal came at the end of the Tokyo Round, 
and there was no time to discuss it at those meetings.25) After the GATT 
Tokyo Round, negotiations for an agreement continued at the GATT Uru-
guay Round of Multilateral Trade Negotiations in Punta del Este. In the 
GATT Punta del Este Declaration, it was decided that TRIPS was one of 
the 15 agendas of the Uruguay Round. The declaration statedthe 
following:26)
①In order to reduce the distortions and impediments to international 
trade, and taking into account the need to promote effective and ade-
quate protection of intellectual property rights, and to ensure that 
measures and procedures to enforce intellectual property rights do not 
themselves become barriers to legitimate trade, the negotiations shall 
aim to clarify GATT provisions and elaborate as appropriate new rules 
and disciplines.
②Negotiations shall aim to develop a multilateral framework of princi-
ples, rules and disciplines dealing with international trade in counter-
 24) Duncan Matthews, Globalising Intellectual Property Rights (Routledge, 2002), p.8.
 25) Ibid., pp.9-10.
 26)  General Agreement on Tariffs and Trade (GATT) Punta del Este Declaration, Ministerial 
Declaration of 20 September 1986.
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feit goods, taking into account work already undertaken in the GATT.
③These negotiations shall be without prejudice to other complementary 
initiatives that may be taken in the World Intellectual Property Organ-
ization and elsewhere to deal with these matters.  
The TRIPS negotiation began at the GATT Uruguay Round. During 
these talks, a dispute arose between the developed and the developing 
counties on continuing the standards of protection. Developing counties 
were also opposed to the Agreement, because it clearly reflected the de-
mands industries of the United States. Another disputed point concerned 
under which legal framework, GATT or WIPO, the TRIPS Agreement 
would be carried out. The negotiations between the developed and devel-
oping countries made slow progress.27) Finally, the negotiations on the 
TRIPS Agreement reached a consensus through ‘linkage bargain diploma-
cy’28) in which the United States and the European Committee (EC) com-
promised with the developing countries on agreements related to textiles 
and agriculture.29) The TRIPS Agreement was enacted as Annex 1C of the 
Marrakesh Agreement establishing the World Trade Organization, signed 
in Marrakesh, Morocco on 15 April 1994, and took effect in 1995.
The TRIPS Agreement determines regulations and procedures which 
promote the protection of intellectual property rights. The aim of the 
TRIPS Agreement was the comprehensive protection of intellectual prop-
erty rights, for example, Copyrights and Related Rights, Trademarks, Geo-
graphical Indications, Industrial Designs, Patents, Layout-Designs (Topog-
raphies) of Integrated Circuits, Protection of Undisclosed Information and 
Control of Anti-Competitive Practices in Contractual Licenses (Part II of 
this Agreement). WIPO conventions provide the legal basis of the TRIPS 
Agreement.30) The Berne Convention deals with the protection of literary 
and artistic works, and the Paris Convention deals with the protection of 
industrial properties. The Principles of the Agreement are that the TRIPS 
Agreement complements these conventions. It regulates not only the pro-
tection standards for intellectual property but also the procedures for the 
 27) About the TRIPs Agreement negotiation, see Op. cit. (Matthews), pp.30-45. 
 28)  Michael P. Ryan, Knowledge Diplomacy: Global Competition and the Politics of Intellectual 
Property (The Brookings Institution, 1998), p.92.
 29) Op. cit. (Matthews), p.45.
 30) Op. cit. (Matthews), p.46.
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resolution of disputes by using the WTO dispute resolution mechanism. 
Under the Agreement, member states are obligated to protect intellectual 
property rights, to provide procedures which anyone can apply to secure 
the intellectual rights in each member state and to take effective remedial 
action against the infringement of intellectual property rights. The mem-
ber states are also obligated to accord to the nationals of other member 
states treatment no less favourable than that it accords to its own nation-
als with regard to the protection of intellectual property (Article 3) and 
most-favoured-nation status (Article 4) on the protection of intellectual 
property rights. The protection and enforcement of intellectual property 
rights ‘should contribute to the promotion of technological innovation and 
to the transfer and dissemination of technology, to the mutual advantage 
of producers and users of technological knowledge and in a manner condu-
cive to social and economic welfare, and to a balance of rights and obliga-
tions’ (Article 7). Member states ‘may, in formulating or amending their 
laws and regulations, adopt measures necessary to protect public health 
and nutrition, and to promote the public interest in sectors of vital impor-
tance to their socio-economic and technological development, provided that 
such measures are consistent with the provisions of this Agreement’ and 
‘appropriate measures, provided that they are consistent with the provi-
sions of this Agreement, may be needed to prevent the abuse of intellectu-
al property rights by right holders or the resort to practises which unrea-
sonably restrain trade or adversely affect the international transfer of 
technology’ (Article 8).
1-2. The international trade of GMOs in the context of TRIPS
Presently, the development of GMOs is closely related to the TRIPS 
Agreement.31) There is an inclination to treat the TRIPS Agreement as pro-
moting the adoption of GMOs into the food system because the Agreement 
requires member states to protect intellectual property rights such as pat-
ents in each state. Biotechnology applies to food or pharmacy, and, there-
fore, it has been subject to patents. However, patents on natural plants or 
animals, including biotechnological inventions, are highly controversial. 
Patents on natural plants or animals may raise economic, social, environ-
mental and ethical issues in developed and developing countries. In partic-
 31) This section refers to Op. cit.(Zarrilli), pp.35-36.
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ular, concern about these issues results from the fact that it is multina-
tional corporations that obtain most of these patents.32) People are 
concerned that these corporations will dominate the patents on natural 
and bioengineered plants or animals. Then, the corporations could exert 
control over natural and invented plants, and also intervene in the ecosys-
tem and affect food security. 
The TRIPS Agreement, Article 27, determines the subject of the patent. 
It declares that ‘subject to the provisions of paragraphs 2 and 3, patents shall 
be available for any inventions, whether products or processes, in all fields of 
technology, provided that they are new, involve an inventive step and are ca-
pable of industrial application’, and ‘patents shall be available and patent 
rights enjoyable without discrimination as to the place of invention, the field 
of technology and whether products are imported or locally produced’ (Article 
27.1).33) On the other hand, this provision includes an exception. 
Article 27: Patentable Subject Matter
2. Members may exclude from patentability inventions, the prevention with-
in their territory of the commercial exploitation of which is necessary to 
protect order public or morality, including to protect human, animal or 
plant life or health or to avoid serious prejudice to the environment, pro-
vided that such exclusion is not made merely because the exploitation is 
prohibited by their law.
3. Members may also exclude the following from patentability:
(a) diagnostic, therapeutic and surgical methods for the treatment of hu-
mans or animals and 
(b) plants and animals other than micro-organisms, and essentially biolog-
ical processes for the production of plants or animals other than non-bio-
logical and microbiological processes. However, Members shall provide 
for the protection of plant varieties either by patents or by an effective sui 
generis system or by any combination thereof. The provisions of this sub-
paragraph shall be reviewed four years after the date of entry into force 
 32)  For a detailed analysis of the issue see Geoff Tansey, “Trade, intellectual property, food and 
biodiversity: Key issues and options for the 1999 review of Aericle 27.3(b) of the TRIPS 
Agreement”, Discussion Paper, Quaker United Nation Office (1999) <www.quno.org/econ-
omicissues/intellectual-property/intellectualLinks.htm> (accessed 2 August, 2011).
 33)  Agreement on Trade-Related Aspects of Intellectual Property Rights <http://www.wto.org/
english/tratop_e/trips_e/t_agm0_e.htm> (accessed 8 August, 2011).
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of the WTO Agreement.
Article 27 stipulates that patents will be available for any inventions 
‘in all fields of technology, provided that they are new, involve an inventive 
step and are capable of industrial application’. According to this stipula-
tion, there is a question of whether natural resources can be the subject of 
a patent, because biotechnology is regarded not as an innovation but as a 
mere discovery of substances found in nature.34) Moreover, according to Ar-
ticles 27.2 and 3, member states do not have to grant patents for these ex-
ceptions. However, this does not mean that they cannot issue patents in 
these areas. On the other hand, biotechnology has found a way to use the 
isolated substances found in natural resources; hence, it can be said that 
biotechnology is an invention. Article 27.3(b) also states that ‘members 
shall provide for the protection of plant varieties either by patents or by 
an effective sui generis system or by any combination there of’. The matter 
is still controversial.35) 
Practically speaking, whether natural plants, including GMOs, may 
be patented depends on the definition in the national law of a particular 
country. GMOs are, in fact, the subject of the patents in most member 
states of the TRIPS Agreement. In the United States, patents for GMOs 
have been applied since the 1980s. There are patents on the technique for 
introducing genes, the technique for adjusting the expansion of the gene, 
the technique for phenotype modification and so on. The number of appli-
cations for patents on GMOs has increased rapidly since 1993.36) As of 
1998, one American company (Monsanto) represented more than 80 per-
cent of the patents for GM seeds in the United States.37) In Japan, the 
number of applications for patents on GM rice has been on the rise since 
the 1990s. For GM rice alone, Japanese companies and research centres 
represented 70 percent of the patents, and companies of the United States 
 34)  Hanns Ullrich, “Traditional Knowledge, Biodiversity, Benefit-Sharing and the Patent Sys-
tem: Romantics v. Economics?”, in Francesco Francioni and Tullio Scovazzi (eds.), Biotech-
nology and International Law (HART Publishing, 2006), p.204.
 35) Idem.
 36)  Japan Patent Office (JPO), “The GMOs form the perspective of the patent: the condition 
concerning about GM rice” <http//www.jpr.go.jp/shiryou/tt1301-015.htm> (accessed 10 Au-
gust, 2011), p.4.
 37)  Rural Advancement Foundation International 13/30/1999 Communiqué: The Gene Gants 
<http// www.rafi.org/> (accessed 9 August, 2011), p.11. 
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represented 15 percent of patents in Japan in 2000.38) At a glance, these 
patents appear to be dominated by the biotechnological industry.
The revision of Article 27.3(b) is one of the ‘built-in agendas’ of the 
conclusion of the Uruguay Round. The WTO Council for TRIPS has contin-
ued to discuss the revision of Article 27.3(b) since 1999; however, member 
states have not yet reached a consensus.39) India has proposed an amend-
ment that would require patent applicants to disclose ‘the source of origin 
of the biological resources and associated traditional knowledge, and to 
provide evidence of prior informed consent and benefit sharing’.40) The Eu-
ropean Union (EU) would support the proposal, which requires mandatory 
disclosure of the origin of the biological resources; however, the EU might 
recommend domestic regulations to regulate the disclosure of information 
about the origins.41) The African Group has proposed an amendment for 
Article 27.3(b) to prohibit patenting of natural and modified plants or ani-
mals or micro-organisms, and ‘to classify traditional knowledge as a cate-
gory of intellectual property rights’.42) 
It is highly controversial to have a multilateral legal framework for 
disclosing the source of origin of biological resources, including traditional 
knowledge. Since the United Nations (UN) Conference on the Environ-
ment and Development of Rio de Janeiro in 1992, the concept of the pro-
tection of traditional knowledge, such as plants which might possibly have 
the potential for nutrition or medical applications, has been a key concept 
for those who oppose the domination of the intellectual goods trade by 
industries.43) It is necessary to control access to genetic resources found in 
natural plants or animals, and to share the benefits among the patents 
that are granted, the original individuals who possess inherited traditional 
knowledge from their ancestors and the public domain. GMO technology-
related traditional knowledge is also the subject to protection.
In a practical sense, the standards for disclosure of the source depend 
on the national regulations, and they are different for each state and each 
 38) Op. cit. (JPO), p.7.
 39) Op. cit. (Zarrilli), p.35.
 40) Idem.
 41)  ICTSD and IISD, the Doha Round Briefing Series, Intellectual Property Rights Vol.2, No.5 
(2003).
 42) Op. cit. (Zarrilli), p.35.
 43) Op. cit. (Ullrich), p.201.
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region.44) For example, the Andean Pact Decision 391 prescribed that ‘any 
intellectual property rights or other claims to resources shall not be con-
sidered valid if they were obtained or used in violation of the terms of a 
permit for access to biological resources residing in any of the Andean 
countries’.45) Under the Indian Patent (Second Amendment) Bill of 1999, if 
the patent holders did not disclose the source of origin of the biological re-
source or knowledge, or they disclosed the wrong source of origin, their 
patents would be rejected or revoked. Patent applicants must disclose the 
source of origin of the biological material when they apply for the patents. 
Moreover, section 6 of the Indian Biodiversity Bill declares that anyone 
who seeks any kind of intellectual property rights based on a biological re-
source or knowledge has to obtain the prior approval of the National Bio-
diversity Authority (NBA) in India. ‘The NBA will impose benefit-sharing 
conditions’.46) The EU directive on the Legal Protection of Biotechnological 
Inventions refers to the disclosure of information on the origin of biological 
materials in its preamble: ‘Whereas if an invention is based on biological 
material of plant or animal origin or if it uses such material, the patent 
application should, where appropriate, include information on the geo-
graphical origin of such material, if known; whereas this is without preju-
dice to the processing of patent applications or the validity of rights aris-
ing from granted patents’ in the Preamble 27 of the European Parliament 
and the Council of the EU.47)
However, the difference in regulations for the disclosure of informa-
tion on the origin between each state has been a source of disagreement. 
In fact there was a trade dispute between the United State and the EU 
concerning GMOs. The TRIPS Agreement was not applied in this case in-
stead. The dispute concerning GMOs was first raised by the United 
States against the EU within the framework of the WTO Agreement on 
the Application of Sanitary and Phytosanitary Measures (SPS 
 44)  Carlos M .Correa, “Traditional Knowledge and Intellectual Property: Issues and options 
surrounding the protection of traditional knowledge”, Discussion Paper, Quaker United 
Nations Office (2001) <http://www.quno.org/geneva/pdf/economic/Discussion/Traditional-
Knowledge-IP-English.pdf> (accessed 8 August, 2011).
 45) Op. cit. (Zarrilli), p.35.
 46) Idem.
 47)  Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the le-
gal protection of biotechnological inventions, Official Journal Legislation /213, 30 July 
1998, pp. 13-21.
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Agreement).48) The disagreement illustrates the difficulty in harmonizing 
regulations for GMO trade between member states. GMOs are closely tied 
to the regulations laid out in the SPS Agreement. Within the WTO frame-
work, it is strictly prohibited that SPS restrictions be used as an excuse 
for placing limitations on imports. The EU adopted Directive 90/220 on the 
deliberate release of GMOs on 23 April49) 1993, and other directives con-
cerning approval procedures and labelling requirements for the release 
and disclosure of GMOs and GM products. Until October 1998, the EU ap-
proved 18 biotechnological products pursuant to the procedures provided 
in Directive 90/220, but between then, and until 2003, the EU approved 
GM products only under the simplified procedure of the Novel Foods Regu-
lation (258/97) of 27 January 1997.50) Six European Economic Community 
(EEC) member states adopted marketing and import bans on biotechno-
logical products previously approved by the European Community (EC).51) 
This seemed to represent a moratorium pending the adoption and entry 
into force of new, stricter the EC directives and regulations for the approv-
al, labelling and traceability of GMOs and GM products.52) This EU atti-
tude was influenced by the 1992 UN Biodiversity Convention and the 
2000 Cartagena Protocol because these texts ask contracting states to re-
view or develop their national biosafety rules with the help of the capaci-
ty-building initiatives of the UNEP Global Facility.53) The United States 
asserted that the EU had de facto placed a moratorium on the approval of 
imports of biotechnological agricultural or food products, which the United 
States inferred from the lack of any biotechnological products from the 
United States being imported between October 1998 and August 2003,54) 
and that certain EC member states maintained national marketing and 
import bans on biotech products even though these products had already 
been approved by the EC for import and marketing in the EC. The United 
States requested formal dispute settlement consultations with the EC. 
 48)  For a detailed description and analysis see Ernst-Ulrich Petersmann, “The WTO Dispute 
over Genetically Modified Organisms: Interface Problems of International Trade Law, En-
vironmental Law and Biotechnology Law”, in Francesco Francioni and Tullio Scovazzi 
(eds.), Biotechnology and International Law (HART Publishing, 2006), pp.173-174.
 49) Official Journal of the European Communities, Legislation 117/ 15 (1990).
 50) Op. cit. (Petersmann), p.174.
 51) Idem.
 52) Idem.
 53) Ibid., p.175.
 54) Ibid., p.176.
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Other countries such as Argentina, Brazil, Canada, Colombia, Mexico, 
New Zealand and Peru joined the consultation.55) They claimed that the 
general EC moratorium, the product-specific moratoria and the EC mem-
ber state marketing or import bans violated the SPS Agreement.56) Against 
these claims, the EC emphasized that there were no general or specific 
moratoria decisions and that the delays in EC approval procedures had 
been justified.57) In the end, the EU lost the lawsuit. The WTO dispute set-
tlement panel concluded that member states may be required not to dis-
tort the SPS Agreement unless there is scientific evidence for the risk as-
sessment. The uncertainty about risk assessment or policies which do not 
underlie the scientific evidence could not be reasons for distorting the SPS 
Agreement. The precautionary principle was not accepted as a general 
principle of law. It does not mean that a member state could not take a 
preventive approach. The EU has urged the other member states to give 
their approval quickly. The member states may establish rules at the na-
tional level, but they should be based on the SPS Agreement.58)
Concerning the rights of plant breeders, most developed countries be-
lieve that the model provided by the Union Internationale pour la Protec-
tion des Obtentions Végétales (International Union for the Protection of 
New Varieties of Plants [UPOV]) system is the most appropriate to afford 
protection to plant varieties. On the other hand, developing countries want 
to retain flexibility in implementing regulations in this field.59) The UPOV 
system is very useful in helping GMO industries by providing quite strong 
protection for the intellectual property rights regime for plant varieties. 
Under the system, commercially bred varieties for industrial agricultural 
systems are promoted. Farmers have to pay royalties on seeds or plants 
which were developed by the chemical and biotechnology industries.60) 
Countries characterized by subsistence farming have submitted alterna-
tive solutions with special regulations for protecting plant varieties appro-
priate to each situation, so that there has been no legal protection of plant 
varieties at the national or international level. In developed countries, the 
 55) Idem.
 56) Ibid., pp.176-179.
 57) Ibid., pp.180-183.
 58) Ibid., pp.187-191.
 59) Op. cit. (Zarrilli), p.36.
 60) Idem.
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private sector has acquired patents and the rights of plant breeders, and 
this was one cause of the development of their seed industries. The majori-
ty of developing countries did not have national legislation for protecting 
plant variety before the implementation of the TRIPS Agreement.61) 
2.  THE RESONANCE BETWEEN THE LEGAL SYSTEM AND GMOS FROM 
THE PERSPECTIVE OF THE AUTOPOIETIC SYSTEM  
2-1. The legal system
The trade-restrictive measures implemented under the Cartagena 
Protocol on Biosafety, which is an international agreement for the safe 
handling, transport and use of living modified organisms (LMOs) and 
which entered into force on 11 September 2003,62) may affect GMOs and 
GM crops, including patented technology, because there is a possibility 
that members of the TRIPS Agreement may lose their rights under the 
Protocol.63) An additional concern is how much responsibility patent hold-
ers and licensees will have when the application of biotechnology has ad-
verse consequences for the environment and the well-being of humans.64)
Therefore, how the legal system recognizes the risk assessment for 
GMOs is very important. An autopoietic system analysis may clarify the 
relationship between the legal system and environment. The autopoietic 
system dealt with in this article is a closed system which produces its own 
components by self-reference. In addition, inside the system, there are 
some closed sub-systems which form a hyper-cycle. According to the theory, 
societies can be analysed as a self-referential system of communications. 
Communication has been differentiated into its functions in the social sys-
tem, and these systems have formed many sub-systems which have been 
specialized by their functions-for example, the political system, the eco-
nomic system, the legal system and so on.65)   
 61)  Philippe Cullet, Protecting rights in plant varieties(Center for International Development 
at Harvard University, 1999) <http://www.cid.harvard.edu/cidbiotech/comments/com-
ments56.htm> (accessed 11 August, 2011).
 62)  The convention on Biological Diversity, <http://bch.cbd.int/protocol/> (accessed 11 August, 
2011).
 63) Op. cit. (Zarrilli), p.36.
 64) Idem.
 65)  For a detailed description see Niklas Luhmann, Social Systems (Stanford University Press, 
1984), Ecological Communication (University of Chicago Press, 1989), Law as a Social Sys-
tem, Klaus A. Ziegert (trans.), Fatima Kastner, Richard Nobles, David  Schiff and Rosam-
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The code of the legal system, which distinguishes between the inter-
nal and external system, is legal/illegal. Inside this system, the code judg-
es that a case is legal or illegal.66) When it is judged as legal, this means 
that the case is not illegal. The code guarantees the legal justification for 
the case. Only the legal system can make a decision about what is legal in 
the legal system itself. Even if it is true that the decision of the system can 
influence other systems through resonance, this may occur only within the 
legal system. Programmes of the legal system, which are the criteria for 
the code, are legal norms, viz., laws, ordinances, statutes, procedural rules, 
judicial rulings and contractual agreements, and judicial precedents67). 
These programmes determine the content of the communication as the op-
eration of the system. The system only communicates about legal norms 
which are regarded as valid. The validity of legal norms is also given by le-
gal norms. To put it succinctly, superior legal norms apply the inferior 
ones. This does not mean that norms produce other norms, because norms 
are produced through the operation of the political system (= legislative 
communication). Hence, communication within the legal system is based 
on which norms apply to a lawsuit or how to apply norms to it. Then the 
validity of the norms is the eigenvalue. The validity of norms stabilizes the 
legal system.68) In continuing communication, the legal system is closed. 
The court is an apparatus which ensures that conditions continue to guar-
antee such communication, which produces other communication for self-
reference inside the legal system.69) The function of the legal system for 
the whole social system is to enable people to predict the results of their 
action in society, particularly to predict what will happen when a legal dis-
pute occurs, and to maintain order in society. Communication in the legal 
system has led to ‘a social desire for order’, and the legal communication of 
order is related to freedom, which can be protected or restricted by legal 
norms.70) The legal system ‘can be developed only as a social regulative’.71)  
und Ziegert (eds.), (Oxford University Press, 2004) and Gunther Teubner, Law as an Au-
topoietic System (Blackwell, 1993).
 66) Op.cit.(Luhmann, 1989), p.64.
 67) Ibid., p.64.
 68)  Heinz von Foerster who researched the cybernetics introduced the concept of the eigenval-
ue in his book Sicht und Einsicht in 1985 (Carl- Auer-System Verlag, 2005).
 69) Op. cit. (Luhmann, 1989), p.64.
 70) Ibid., p.65.
 71) Ibid., p.67.
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2-2. The resonance between the legal system and the environment 
For the legal system, the risk assessment of GMOs is an environmen-
tal event. There are four concepts relevant to the relation between the le-
gal system and the environment. The first is ‘external observation’, by 
which the system observes the environment according to its code. The sec-
ond is ‘resonance’, which is a stimulus for a system from the environment. 
When a system observes the environment of the system, then the reso-
nance will happen. The third is ‘operational coupling’, which means that 
some of the operations of one system are also simultaneously some of the 
operations of another system.72) The fourth is ‘structural coupling’, which 
means that part of the structure of one system depends on another sys-
tem. Even though the two systems are in a state of structural coupling, 
each system reacts to an event at a different pace. There is synchronicity 
between each operation of the two systems, but it does not guarantee the 
synchronization of the operation of both of them.73)
The legal system easily resonates with the political system, so that 
the legal system requires decisions which bind together any groups formed 
by the political system. The legal system requests that the political system 
do much more than it can actually do.74) The legal system is closed; howev-
er, this system must observe the environment to apply an appropriate 
norm to a case or to check the appropriateness of norms or to judge the ne-
cessity to change the norms, and it causes resonance with the environ-
ment. In this sense, the legal system is open.75) Only in this way can the le-
gal system understand events related to the environment. When a legal 
dispute concerning GMOs occurs, the legal system attempts to resonate 
with the environment by transforming an economic, a political or social 
event into a legal event. Any communication which is excluded from the 
legal system, for example, the estimation of risks, is always regarded as 
communication of the political system. Although the expectations of the 
political system give the illusion that the system can control matters for 
the whole social system, the legal system has, in fact, more occasions in 
 72) Op. cit. (Luhmann, 2004), p.381.
 73) Ibid., p.383.
 74) Op. cit. (Luhmann, 1989), p.63.
 75) Ibid., p.65.
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which to arbitrarily decide on environmental matters.76) ‘The component of 
arbitrariness in environmentally related legal decisions increases 
significantly’.77) The situation occurs in three respects; first, ‘for the neces-
sity of defining marginal values, thresholds and units of measure for 
which the environment supplies no determination’; second, ‘for determin-
ing the system’s willingness to assume or tolerate risks and eventually 
those that discount the costs or even proscriptions’ and third, ‘for fixing 
preferences regarding the extremely diverse consequences of environmen-
tal changes that are in large measure blocked, scattered and concealed by 
the price mechanism or even for the protection of concerned interests that 
cannot be co-ordinated immediately because of the indirectness and opaci-
ty of causal relations’.78)
These are new problems for the legal system. However, given the op-
portunity, the legal system can increasingly resonate with environmental 
events. This, in fact, depends on how the legal system deals with the risk 
assessment in the system. The WTO dispute settlement panel, regarding a 
trade dispute between the United States and the EU concerning GMOs, 
concluded that member states may be required not to distort the WTO 
Agreement unless there is scientific evidence to do so. The uncertainty of 
the risk assessment or policies for which there is no underlying scientific 
evidence cannot be a reason to distort the WTO Agreement. However, 
there are some concepts or principles, such as the Cartagena Protocol on 
Biosafety, which introduce restrictive trade measures affecting GMOs and 
GM crops, including patented technology. Both risk assessment and the 
concept of the protection of traditional knowledge are in effect since the 
United Nations Conference on the Environment and Development may act 
as a brake on the arbitrary domination of the private sector in the field of 
GMO trade, which is supported by the TRIPS Agreement. This depends on 
whether the legal system recognizes people’s concern about multinational 
corporations’ domination of patents on natural and bioengineered plants 
or animals. More specifically, the question of whether natural resources 
can be the subject of patents has not been deleted from the interpretation 
of Article 27 in the TRIPS Agreement. Regulation based on risk assess-
ment may also bring advantages for GMO industries because it may help 
 76) Ibid., p.68.
 77) Idem.
 78) Ibid., pp.68-69.
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to solve the problem of how much responsibility patent holders and licen-
sees will have for the adverse consequences to the environment and hu-
man well-being that result from the application of biotechnology. There-
fore, these communications outside of the legal system could be inputs to 
the system.
Moreover, in the fields of economics, tele-informatics, health care and 
advanced science and technology in which public legalization has not been 
advanced, private international associations make voluntary rules by 
themselves. These rules, called ‘the global law’, have attracted the atten-
tion of practitioners and scholars in international relations and interna-
tional law.79) It is undesirable for private actors to be subject rules made by 
the government, and it is necessary for them to be allowed to operate free-
ly. Global law, which is formed voluntarily by the free activities of private 
actors, is expected to play an effective role in global governance. In fact, 
some international private organizations have already developed funda-
mental norms or constitutional rules which determine the enforcement, 
abolition, procedures and alteration of primary rules.80) They have also de-
cided how to deal with any protest against primary rules.81) For example, 
the International Chamber of Commerce (ICC) already has an adjudica-
tive institution which deals with commercial disputes among members. 
The ICC International Court of Arbitration is a permanent organ of inter-
national commercial arbitration which was founded to solve business dis-
putes of an international character. Most recent business contracts refer to 
the ICC rules of Arbitration and ICC Rules of Conciliation.82) For patents, 
the International Organization for Standardization (ISO) and the Interna-
tional Electrotechnical Commission have established rules for the patent-
 79)  Jacques Lenoble and Marc Maesschalck (eds.), Toward a Theory of Governance (Kluwer 
Law International, 2003).
 80)  Nikolas Tsagourias, “Introduction-Constitutionalism: A Theoretical Roadmap”, in Nikolas 
Tsagourias (ed.), Transnational Constitutionalism (Cambridge University Press, 2007), 
pp.1-2., and David Sciulli, Theory of Societal Constitutionalism: Foundation of a Non-
Marxist Critical Theory (Cambridge University Press, 1992).
 81)  H.L.A. Hart, The Concept of Law (Oxford University Press, 1997), Ch.5., and Noberto Bob-
bio, “Nouvelles reflexions sur les norms primaries et les norms secondaires”, dans Etudes 
publiées par Pérelman, Ch., La règle de droit (Bruylant, 1971), pp. 113-115 et 119.
 82)  International Chamber of Commerce (ICC) rules of Arbitration in force as from 1 January, 
1998, ICC Rules of Conciliation in force as from 1 January, 1998, ICC Publication No.581 
(1997).
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ing of photography.83) It is possible that GMO trade or patenting will also 
be regulated by global law. 
CONCLUSION 
This study aims to examine the connection between the international 
trade of GMOs and the WTO Agreement on Trade-Related Aspects of In-
tellectual Property Rights (TRIPS), and to clarify issues of GMO trade in 
the WTO legal framework. In the introduction, this paper has offered an 
outline of GMOs classified by three generations, and the expansion of 
first-generation GMO trade. It also explained the concerns about GMOs in 
relation to human healthcare and the environment. In the first section, 
this paper dealt with the history of the establishment of the TRIPS Agree-
ment, and clarified issues concerning the international trade of GMOs in 
the context of the Agreement. On the context of the TRIPS, how define the 
GMO is significant. If the GMO is regarded not as an innovation but as a 
mere discovery of substances found in natural resources, it is difficult to 
be the subject of a patent. If the GMO is regarded as an invention, it can 
be the subject of a patent and the TRIPS Agreement. Today, whether 
GMOs may be patented depends on the definition in the national law of a 
particular country. However there is conflict between national laws and 
the WTO legal frame work such as the lawsuit described between the 
United States and the EU. In the second section, this paper explained the 
characteristics of the legal system as viewed from the perspective of the 
autopoietic system, and discussed the possibility of resonance between the 
legal system and the environment concerning GMOs to regulate the GMO 
trade. The concept of the protection of traditional knowledge has been a 
key concept for those who oppose the domination of the intellectual goods 
trade by industries. GMO technologyrelated traditional knowledge is also 
the subject to protection. The risk assessment of GMO to effect the envi-
ronment or the human body is also a key concept of the regulation of GMO 
trade. From now on, the communication about these concepts would rise 
up outside of the legal system, itmust need to resonate with the environ-
mental event such as the formation of the concept of traditional knowledge 
 83)  Jonathan G.S. Koppell, World Rules: Accountability, Legitimacy, and the Design of Global 
Governance (University of Chicago Press, 2010), pp.284-285.
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or the risk assessment of GMOs to regulate international GMO trade. Not 
only the public international laws but also the Global law which is formed 
voluntarily by the free activities of private actors, is expected to play an ef-
fective role in the regulation of the GMO trade. This paper cannot deal 
with the relation between the risk assessment and the law. This relation-
ship is very important for the regulation of advanced science and technolo-
gy. This issue will be deeply researched in my future study.
It has been only about 20 years since first-generation GM crops were 
introduced into the market. The direct impact of GMOs or GM plants on 
human health, animals and the ecosystem is still unknown scientifically 
because there are no people who have eaten GM foods for decades, and 
there are no places where GM plants have been bred for decades. The GMO 
trade tends to expand every year regardless of the increasing number of 
people who question the safety of GM foods and their influence on human 
health and the ecosystem. In addition, the chemical and pharmaceutical 
industries’ domination of patents for GMOs is also a risk for GMOs. It is 
very difficult for the WTO legal framework to estimate the risks in the fu-
ture. The potential damage from these risks can be regarded as the result 
of decisions made by the legal system because the function of this system 
for the whole social system is to enable people to predict their actions in 
society, and to maintain order in society. The WTO legal system as it re-
lates to GMOs has resonated with the economic system, particularly the 
chemical and the pharmaceutical industry. For example, the establishment 
of the TRIPS Agreement is called ‘a victory for U.S. industry’, so the TRIPS 
Agreement was the fruit of lobbying of large companies of the United 
States.84) Then and only then, in the true sense, does the risk become a 
problem of the legal system, when the legal system starts to consider 
whether to run a risk concerning GMOs.85) For this to continue, communi-
cation about the risk concerning GMOs and its trade with respect to the 
environment of the legal system may be the most significant issue. It may 
promote resonance between the legal system and the environment. 
 84) Op. cit. (Matthews), p.45.
 85) Niklas Luhmann, Soziologie des Risikos (Walter De Gruyter Inc., 2003), p.235.
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